EUFOREA treatment algorithm for allergic rhinitis
EUFOREA treatment algorithm for allergic rhinitis
Allergic rhinitis (AR) is the most common chronic inflammatory disease, affecting an estimated 100 million Europeans (1). Despite a substantial burden on individuals, society and health economies (2), AR remains under-diagnosed, under-estimated (in terms of severity), and under-treated (3). Although effective and safe treatments exist, patients wait too long to seek medical advice, often preferring to self-manage at drug stores and at the pharmacy (4).
618-622
Hellings, P W
5d7f036f-7c9b-43d4-9503-320ec5350209
Scadding, G
cbf15f6d-2c0f-40b6-b758-9be7306fa43b
Bachert, C
d5e97158-d120-4008-9c54-892c4ca141d6
Bjermer, L
5e4be066-ed75-4f31-9e28-dc502cc7c0a4
Canonica, G W
1a2769c1-7a4a-4b60-bab2-4ef2c087f1e1
Cardell, L O
ebc5572b-2ac0-4ca9-806c-cd24cea64c25
Carney, A S
b1784568-7dc7-4eb3-83e0-915baa33e0cb
Constantinidis, J
1a511f14-cd0a-4709-b109-3de92e9855d4
Deneyer, L
0900f869-5d5f-4411-b3c5-2cc146e5aae5
Diamant, Z
b5d27a33-e484-4e12-b75c-202a04a2e2e2
Durham, S
fad2d5de-ec3c-4f7b-aebc-2e6218b727e9
Gevaert, P
6711ddc6-24d0-4afa-8158-1bdadc561516
Harvey, R
b9540468-ec32-43c7-a6b4-92939ae46cbb
Hopkins, C
2f212158-65e9-4d25-abfb-b81e4314021c
Kjeldsen, A
3bffb92a-77a5-455a-891e-036bfbd071e6
Klimek, L
a88e9033-0dc2-45c0-826a-0384338abf8a
Lund, V J
b04f5441-1bf2-4a03-b0c6-e90c5520bc59
Price, D
7534eb51-9b20-4840-9604-f34a428c855c
Rimmer, J
e5bff301-729c-4523-a5b4-387fdb9c8db9
Ryan, D
589805c9-f59f-44d3-a2b1-7924e9566612
Roberts, G
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Sahlstrand-Johnson, P
dd791ac1-20db-4c82-94f2-87dcee894139
Salmi, S
618a3bcf-b952-46cb-b710-86dfd8e7a88d
Samji, M
6b4df53e-8e71-4b56-8f0e-1a43dde3b048
Scadding, G
cbf15f6d-2c0f-40b6-b758-9be7306fa43b
Smith, P
11f678ab-4aee-426a-aedd-19719d80bbbc
Steinsvik, A
52849372-76e8-4578-ae8b-d36037cd2a5f
Wagenmann, M
7b236356-bbf5-4485-9291-3f5c76ab5f25
Seys, S
0163ccee-89c7-4802-9419-cc236c03a83d
Wahn, U
e791619f-bfb4-467a-addc-2e992104479e
Fokkens, W J
52a2db87-9e81-4306-b93b-c1a59865f986
1 December 2020
Hellings, P W
5d7f036f-7c9b-43d4-9503-320ec5350209
Scadding, G
cbf15f6d-2c0f-40b6-b758-9be7306fa43b
Bachert, C
d5e97158-d120-4008-9c54-892c4ca141d6
Bjermer, L
5e4be066-ed75-4f31-9e28-dc502cc7c0a4
Canonica, G W
1a2769c1-7a4a-4b60-bab2-4ef2c087f1e1
Cardell, L O
ebc5572b-2ac0-4ca9-806c-cd24cea64c25
Carney, A S
b1784568-7dc7-4eb3-83e0-915baa33e0cb
Constantinidis, J
1a511f14-cd0a-4709-b109-3de92e9855d4
Deneyer, L
0900f869-5d5f-4411-b3c5-2cc146e5aae5
Diamant, Z
b5d27a33-e484-4e12-b75c-202a04a2e2e2
Durham, S
fad2d5de-ec3c-4f7b-aebc-2e6218b727e9
Gevaert, P
6711ddc6-24d0-4afa-8158-1bdadc561516
Harvey, R
b9540468-ec32-43c7-a6b4-92939ae46cbb
Hopkins, C
2f212158-65e9-4d25-abfb-b81e4314021c
Kjeldsen, A
3bffb92a-77a5-455a-891e-036bfbd071e6
Klimek, L
a88e9033-0dc2-45c0-826a-0384338abf8a
Lund, V J
b04f5441-1bf2-4a03-b0c6-e90c5520bc59
Price, D
7534eb51-9b20-4840-9604-f34a428c855c
Rimmer, J
e5bff301-729c-4523-a5b4-387fdb9c8db9
Ryan, D
589805c9-f59f-44d3-a2b1-7924e9566612
Roberts, G
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Sahlstrand-Johnson, P
dd791ac1-20db-4c82-94f2-87dcee894139
Salmi, S
618a3bcf-b952-46cb-b710-86dfd8e7a88d
Samji, M
6b4df53e-8e71-4b56-8f0e-1a43dde3b048
Scadding, G
cbf15f6d-2c0f-40b6-b758-9be7306fa43b
Smith, P
11f678ab-4aee-426a-aedd-19719d80bbbc
Steinsvik, A
52849372-76e8-4578-ae8b-d36037cd2a5f
Wagenmann, M
7b236356-bbf5-4485-9291-3f5c76ab5f25
Seys, S
0163ccee-89c7-4802-9419-cc236c03a83d
Wahn, U
e791619f-bfb4-467a-addc-2e992104479e
Fokkens, W J
52a2db87-9e81-4306-b93b-c1a59865f986